Alexandria Real Estate Equities shares moved lower in Monday trading as the market looked ahead to the company’s first-quarter 2026 results scheduled for release after the closing bell on April 27, 2026. With a report imminent, investors appeared to de-risk exposure to life-science office REITs amid ongoing concerns about near-term leasing and occupancy trends.

Street expectations going into the quarter point to a downshift in fundamentals versus last year, with forecasts calling for revenue of about $666.8 million and adjusted FFO of roughly $1.74 per share. The core narrative weighing on sentiment is that occupancy is expected to be pressured by a large block of expiring space and the associated downtime, which can temporarily depress same-property revenue and NOI even if longer-term demand stabilizes. (zacks.com)

ARE has been navigating a tougher capital-markets and leasing environment for life-science space, where re-leasing timelines and pricing power have been under pressure. The company has also highlighted balance-sheet and portfolio actions (including dispositions) as it works through a 2026 “trough” period, keeping the stock more reactive to incremental signals on occupancy, NOI, and forward guidance than it was in prior cycles. (prnewswire.com)